This study was undertaken to compare the rate of abnormal glucose levels measured after 1 hour (>140 mg%) with those measured after 2 hours (>120 mg%) postprandially in women with gestational diabetes mellitus (GDM). STUDY DESIGN: Sixty-eight women were included in this study. All had GDM based on the criteria of Carpenter-Coustan. Women with fasting glucose levels of 105 mg% or more were excluded from the study. All women were initially treated by diet. All women measured daily capillary blood glucose levels when fasting as well as 1 hour and 2 hours postprandially for 1 week, immediately after diagnosis of GDM. Glucose levels were obtained by memory-based glucometers. All women were followed in a specialized gestational-diabetes clinic throughout the pregnancy. Insulin therapy was started on an individual basis according to common clinical criteria. Epidemiologic and perinatal data were collected from medical charts.
Gestational diabetes mellitus (GDM), which complicates between 3% and 5% of all pregnancies, is associated with an increase in perinatal morbidity. 1 Studies have shown that postprandial glucose levels are most predictive of outcomes in these pregnancies. 2 The current practice is to monitor blood glucose levels by measuring them after each meal (postprandial) in addition to fasting. 3, 4 What has not been established, however, is the best timing of these postprandial levels, ie, 1 or 2 hours after meals. The 4th International Workshop Conference on GDM suggested thresholds of 140 mg% at 1 hour or 120 at 2 hours to reduce the risk of macrosomia. 5 These recommendations are presumably based on the assumption that the levels are comparable. However, there have been no studies to date to verify this assumption. The American College of Obstetricians and Gynecologists recommends a cutoff of 120 mg% at 2 hours for women with GDM but indicates that lower thresholds may reduce macrosomia. 6 It was the purpose of this study to compare the rate of abnormal glucose levels measured after 1 hour with those measured after 2 hours postprandially in women with diet-controlled GDM. It was our null hypothesis that there are no differences in the rate of abnormal glucose levels measured 1 or 2 hours after meals.
Methods
Sixty-eight consecutive pregnancies referred to our diabetes-in-pregnancy program at the Sheba Medical Center, Tel-Hashomer, were included in this prospective study. All women were diagnosed with gestational diabetes based on the criteria of Carpenter and Coustan. 7 Women with pregestational diabetes or fasting glucose levels of 105 mg% or more were excluded from the study. On admission, all women were seen by a registered dietitian for individualized counseling and instruction. Women were placed on 1800 to 2200 calorie ADA (American Diabetes Association) diet with the following composition: 40% to 45% carbohydrates, 20% protein, and ≤40% fat. All were given a memory-based blood glucose meter (One Touch Profile, LifeScan Inc, Milpitas, Calif) and instructed to measure capillary blood glucose at fasting and 1 and 2 hours postprandial for approximately 1 week (the study period) immediately after the diagnosis of GDM. Blood glucose levels downloaded directly from the glucose meter to a personal computer in our clinic and were then stored for further analysis (In Touch, LifeScan, Inc). Thereafter, the study ceased, and women continued to measure daily blood glucose levels 1 hour postprandially as per our current management protocol. Quality control measures were performed on the meters before implementation and again at study completion. Insulin therapy was instituted if fasting capillary blood glucose levels exceeded 95 mg% or if 1-hour postprandial levels were greater than 140 mg%, 30% or more of the time. Relevant medical history (ie, personal history of GDM, family history of diabetes) and maternal and neonatal outcome variables were collected from medical records throughout the pregnancy and at the first postpartum visit. The percent of abnormal values for each gravid woman at 1 and 2 hours postprandial (1 hour >140 mg% and 2 hours >120 mg%) for each meal were compared. Statistical analysis using unpaired student t tests and χ 2 analysis were applied where appropriate. Statistical significance was set at P <.05.
Results
Sixty-eight women were enrolled into this study. The mean age of the women was 30.8 ± 5.4 years. Fifty-five percent of women had a family history of diabetes in either a first-degree or second-degree relative. Twenty-seven percent of women had a history of GDM in a previous pregnancy. The mean gestational age at first visit to our specialized diabetes clinic was 28.8 ± 5.4 weeks. Mean body mass index was 25.2 ± 3.9 kg/m 2 before pregnancy and 30.4 ± 3.8 kg/m 2 at delivery, representing an average weight gain of 14.5 ± 6.5 kg. Insulin therapy was instituted in 30% of women throughout pregnancy. The specific demographic variables were analyzed according to the mode of treatment as outlined in Table I . Results of the 1-hour challenge tests and 3-hour oral glucose tolerance tests are shown in Table II .
Glucose measurements included 618 readings during fasting and 2730 either 1 (1400 readings) or 2 hours (1330 readings) postprandial. Compliance for obtaining glucose measurements was 100%, 75%, and 72% during fasting, 1 hour and 2 hours after meals, respectively. Results of the 1-hour and 2-hour postprandial blood glucose levels obtained for the 7-day study period are provided in Table III . The rate of abnormal glucose levels per person were 27.1% during fasting and 17.8% and 17.2% 1 and 2 hours after meals, respectively. Measurements of mealspecific abnormal rates were as follows: postbreakfast, 22.4% after 1 hour versus 8.5% after 2 hours (P = .0002); postlunch, 16.4% and 18.2%, respectively (not significant); and postdinner, 16.3% and 30.1%, respectively (P = .0035). For all 3 meals together, a positive correlation was found between 1-hour and 2-hour postprandial values (r = 0.67, P <.01). However, only in 25% of meals after which there were abnormal glucose readings, were the 1-hour and 2-hour postprandial glucose elevated. In addition, a significant positive correlation was found between fasting blood glucose levels and all postprandial values (r = 0.41, P <.01).
A comparison of women on diet therapy and women on insulin treatment regarding patient characteristics and outcome are shown in Tables I and II, respectively. Women treated with insulin had a significantly higher body mass index both before gestation and at delivery (24.4 ± 3.6 vs 27.3 ± 3.9 pregestational and 29.5 ± 3.1 vs 32.5 ± 4.4 peripartum; P = .016). As expected, fasting glucose levels during the oral glucose tolerance test were significantly higher in women requiring insulin therapy. Insulin-treated patients as a whole had 36.6% abnormal glucose measurements, compared with only 23.7% in the diet-treated group (P = .02). However, this difference was not significant when divided into meal-specific readings. Of the four patients (5.8%) who delivered macrosomic (>4000 g) infants, all were in the diet-treated group. Mean birth weight and gestational week at delivery were not different between the 2 groups. However, there was a significant trend of lower weight percentile in the insulintreated group.
Comment
Although there is evidence to suggest that lowering postprandial blood glucose level will reduce the risk of macrosomia and other perinatal complications in patients with GDM, controlled trials to identify ideal glycemic targets have not been performed. [8] [9] [10] [11] One area of controversy is the timing of blood glucose measurements. It has been shown that insulin-treated patients with GDM who were managed according to results of 1-hour postprandial glucose levels achieved a greater decrease in hemoglobin A1c and had significantly fewer macrosomic infants when compared with patients managed by preprandial glucose levels. 2 Another debate is the place of fasting glucose measurements in contrast to postprandial measurements. It is accepted to measure fasting glucose as well as postprandially. Several retrospective studies have shown that normal fasting plasma glucose levels had a predictive value of 83% to 96% for normal postprandial glucose values 12, 13 (in our study, normal fasting glucose levels had predictive values of 84% and 89% for normal 1-hour and 2-hour postprandial glucose levels, respectively). However, both fasting and postprandial glucose measurements provide independent information that is useful in the management of gestational diabetes. The Fourth International Workshop on GDM recommended lowering capillary blood glucose concentrations to ≤95 mg% in the fasting state, ≤140 mg% at 1 hour, and ≤120 mg% at 2 hours, whereas the American Diabetes Association 14 recommended the option of measuring 1 hour postmeal values with a cut-off of 120 mg%. Yet no consensus was reached regarding the optimal timing of the postprandial measurements (1 hour versus 2 hours). Until more data are available, the timing of self-monitored blood glucose determinations remains at the discretion of the individual clinician.
In the present study, 1-hour and 2-hour postprandial blood glucose levels, for all meals combined, correlated with each other and with values in the fasted state. The unexpected finding of this study was the meal-specific discrepancies observed between the 1-hour and 2-hour values. The rate of abnormal values was 2.5-fold greater 1 hour after breakfast versus 2 hours, in contrast with an opposite ratio of a 2-fold increase in the rate of abnormal values 2 hours after dinner versus 1 hour. The most obvious explanation for these differences is meal composition. One could postulate that an increased proportion of protein and fat consumed by most women at the evening meal might have delayed the absorption of carbohydrates, causing 2-hour values to be higher than 1-hour measurements. In contrast, the increased insulin resistance observed in the early morning hours may explain the increase in 1-hour versus 2-hour values at breakfast. 15, 16 Other explanations included differences in the types of carbohydrates consumed and percentage of carbohydrates consumed at each of the 2 meals. In the future, differential measurement (1 hour after breakfast and 2 hours after dinner) might impose stricter criteria for controlling blood glucose levels. Further clinical research should explore whether differential measurements might reduce the rate of diabetes-associated complications.
Using 1-hour postprandial and fasting blood glucose targets, 33% of the women in our study required insulin therapy. The women who required insulin tended to be heavier before pregnancy and were diagnosed earlier than women who were successfully treated with diet only. Presumably, these women were more insulin-resistant. In addition, women requiring insulin therapy had significantly higher fasting blood glucose levels on their 3-hour oral glucose tolerance test, although the 1-hour, 2-hour, and 3-hour values did not differ between the 2 groups. The rate of macrosomia (5.9%) and other neonatal complications achieved by both groups indicated that our targets and use of 1-hour postprandial values were successful, at least in this population, in preventing these adverse outcomes.
Ideally, any management scheme must take into account lifestyle considerations and patient preferences. It has been our experience that women prefer 1-hour to 2-hour determinations; the closer proximity of testing to meals interferes less with their normal daily activities. It is also our experience that the greater the time between the meals and the determinations of blood glucose levels, the more likely women are to forget and, thereby, cause a reduction in regimen compliance. Therefore, prospective controlled intervention trials are needed to identify the optimal timing of self-monitoring blood glucose determinations. 
